Literature DB >> 26358804

Epidemiology of medications use in pregnancy.

Martina Ayad1, Maged M Costantine2.   

Abstract

The use of prescribed and over-the-counter medications in pregnancy is on the rise. Many women become pregnant at an older age and with preexisting medical conditions that require pharmacotherapy. In addition, pregnancy is associated with profound changes in the physiology of virtually every organ in the body, which affect medications' pharmacokinetics and pharmacodynamics. Despite all of these, pregnant women are still considered therapeutic orphans, as the majority of current therapeutics were never studied in pregnancy. The goals of this review are to synthesize the available information regarding the epidemiology of medications use and the state of drug research in pregnancy, in an effort to highlight the need for pharmacologic research in pregnancy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26358804      PMCID: PMC4628584          DOI: 10.1053/j.semperi.2015.08.002

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  30 in total

Review 1.  Physiologic changes in pregnancy and their effect on drug disposition.

Authors:  M C Frederiksen
Journal:  Semin Perinatol       Date:  2001-06       Impact factor: 3.300

2.  Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

Authors:  Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Katherine E Kelley; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2011-04-22       Impact factor: 8.661

Review 3.  Pharmacometrics in pregnancy: An unmet need.

Authors:  Alice Ban Ke; Amin Rostami-Hodjegan; Ping Zhao; Jashvant D Unadkat
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

4.  Pregnancy and pharmacogenomics in the context of drug metabolism and response.

Authors:  Anders Helldén; Parvaz Madadi
Journal:  Pharmacogenomics       Date:  2013-11       Impact factor: 2.533

5.  A pregnancy testing policy for women enrolled in clinical trials.

Authors:  Toby Schonfeld; Kendra K Schmid; Joseph S Brown; N Jean Amoura; Bruce Gordon
Journal:  IRB       Date:  2013 Nov-Dec

6.  Trends in pregnancy labeling and data quality for US-approved pharmaceuticals.

Authors:  Maryann Mazer-Amirshahi; Samira Samiee-Zafarghandy; George Gray; Johannes N van den Anker
Journal:  Am J Obstet Gynecol       Date:  2014-06-06       Impact factor: 8.661

7.  Sex dependent pharmacokinetics and bioequivalence--time for a change.

Authors:  Gideon Koren
Journal:  J Popul Ther Clin Pharmacol       Date:  2013-11-06

8.  Outpatient use of cardiovascular drugs during pregnancy.

Authors:  Susan E Andrade; Marsha A Raebel; Jeffrey Brown; Kimberly Lane; James Livingston; Denise Boudreau; Sharon J Rolnick; Douglas Roblin; David H Smith; Gerald J Dal Pan; Pamela E Scott; Richard Platt
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-03       Impact factor: 2.890

9.  Prescriptions for category D and X drugs during pregnancy in Taiwan: a population-based study.

Authors:  Li-Ting Kao; Yi-Hua Chen; Herng-Ching Lin; Shiu-Dong Chung
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-02-28       Impact factor: 2.890

Review 10.  Exclusion of pregnant women from industry-sponsored clinical trials.

Authors:  Kristine E Shields; Anne Drapkin Lyerly
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

View more
  24 in total

Review 1.  Anatomical and physiological alterations of pregnancy.

Authors:  Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-06       Impact factor: 2.745

2.  Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies.

Authors:  Romain Demailly; Sylvie Escolano; Françoise Haramburu; Pascale Tubert-Bitter; Ismaïl Ahmed
Journal:  Drug Saf       Date:  2020-06       Impact factor: 5.606

Review 3.  Challenges in conducting clinical research studies in pregnant women.

Authors:  Monique McKiever; Heather Frey; Maged M Costantine
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-04-18       Impact factor: 2.745

4.  Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.

Authors:  André Dallmann; Ibrahim Ince; Juri Solodenko; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

Review 5.  The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.

Authors:  Ian R Mulrenin; Julian E Garcia; Muluneh M Fashe; Matthew Shane Loop; Melissa A Daubert; Rachel Peragallo Urrutia; Craig R Lee
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-11       Impact factor: 4.481

6.  Clinical management of medications in pregnancy and lactation.

Authors:  Lorene A Temming; Alison G Cahill; Laura E Riley
Journal:  Am J Obstet Gynecol       Date:  2016-02-02       Impact factor: 8.661

7.  Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes.

Authors:  Raju Khatri; John K Fallon; Craig Sykes; Natasha Kulick; Rebecca J B Rementer; Taryn A Miner; Amanda P Schauer; Angela D M Kashuba; Kim A Boggess; Kim L R Brouwer; Philip C Smith; Craig R Lee
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

8.  Registered Clinical Trials Comprising Pregnant Women in China: A Cross-Sectional Study.

Authors:  Yi Zhao; Guiping Du; Xiaofei Luan; Hui Yang; Qiongguang Zhang; Zhengfu Zhang; Subiao Wang
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

9.  Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries.

Authors:  Devin D Smith; Jessica L Pippen; Adebayo A Adesomo; Kara M Rood; Mark B Landon; Maged M Costantine
Journal:  Am J Perinatol       Date:  2020-05-19       Impact factor: 1.862

10.  Pregnancy-Related Hormones Increase Nifedipine Metabolism in Human Hepatocytes by Inducing CYP3A4 Expression.

Authors:  Raju Khatri; Natasha Kulick; Rebecca J B Rementer; John K Fallon; Craig Sykes; Amanda P Schauer; Melina M Malinen; Merrie Mosedale; Paul B Watkins; Angela D M Kashuba; Kim A Boggess; Philip C Smith; Kim L R Brouwer; Craig R Lee
Journal:  J Pharm Sci       Date:  2020-09-12       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.